Clinical Trial Update: Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study of buspirone hydrochloride tablets under fasting conditions to assess bioequivalence; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• BuSpar (buspirone hydrochloride)

Snippet

Sponsor: Par Pharmaceutical, Inc. | Conditions: To Determine Bioequivalence Under Fasting Conditions | Phase 1 | Status: COMPLETED